Skip to main content
NCBI home page
RSC Advances logoLink to RSC Advances
. 2022 Jul 1;12(30):19317. doi: 10.1039/d2ra90065c

Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells

Lingling Xu 1,2,†, Chuan Zhou 1,3,†, Fan Wang 4,†, Huiqin Liu 1,3, Guangyuan Dong 1,3, Siyi Zhang 1,2,✉, Tao Liu 1,2,✉
PMCID: PMC9248366  PMID: 35865561

Abstract

Correction for ‘Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells’ by Lingling Xu et al., RSC Adv., 2022, 12, 18004–18011. https://doi.org/10.1039/D2RA02301F.

The authors regret that the equal author contributions and corresponding author indicators were incorrectly shown in the original manuscript. The corrected indicators are as shown in this correction notice.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

Supplementary Material

Articles from RSC Advances are provided here courtesy of Royal Society of Chemistry

RESOURCES